发明名称 |
COMPOUNDS FOR THE MODULATION OF MYC ACTIVITY |
摘要 |
The present invention provides novel compounds of Formulas (I) and (II) and pharmaceutically acceptable salts, solvates, hydrates, tautomers, stereoisomers, isotopically labeled derivatives, and compositions thereof. Also provided are methods and kits involving the compounds or compositions for treating or preventing proliferative diseases, e.g., cancers (e.g., breast cancer, prostate cancer, lymphoma, lung cancer, pancreatic cancer, ovarian cancer, neuroblastoma, or colorectal cancer), benign neoplasms, angio genesis, inflammatory diseases, fibrosis (e.g., polycystic kidney disease), autoinflammatory diseases, and autoimmune diseases in a subject. |
申请公布号 |
WO2016196910(A1) |
申请公布日期 |
2016.12.08 |
申请号 |
WO2016US35690 |
申请日期 |
2016.06.03 |
申请人 |
SYROS PHARMACEUTICALS, INC.;ROBERTS, Christopher;ZHANG, Yi;BEAUMIER, Francis;LEPISSIER, Luce |
发明人 |
ROBERTS, Christopher;ZHANG, Yi;BEAUMIER, Francis;LEPISSIER, Luce;MARINEAU, Jason, J.;RAHL, Peter, B.;SPROTT, Kevin;CIBLAT, Stephen;SOW, Boubacar;LAROUCHE-GAUTHER, Robin;BERSTLER, Lauren |
分类号 |
C07D513/04;A61K31/437;A61P35/00 |
主分类号 |
C07D513/04 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|